NAPc2 prolongs survival in Ebola virus infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1418, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody therapy as a future treatment option for Ebola virus infection

By Matsuno Keita Takada Ayato

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 607-614

Future Medicine

Access to resources Recommend Favorite

The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 361-370

Bentham Science Publishers

Access to resources Recommend Favorite

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

By Baribaud Frédéric Doms Robert W Pöhlmann Stefan

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 423-431

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine prolongs survival in myelodysplastic syndromes

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Rituximab maintenance prolongs survival in NHL

Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite